2022 western region candidates
Candidates are listed alphabetically by last name.
Professor and Head, Washington University School of Medicine, USA
I am enthusiastic to run for nomination to the HUPO governing council this year. I have been a member of this governing council since 2016, the last two years elected as a Member-at-Large in the Executive Committee. In this time, I have enjoyed learning about the HUPO organization and lending my voice and advice to help steer HUPO over these difficult last few years. It’s been a fantastic experience to work with such dedicated scientists on the HUPO Executive Committee. I have also been heavily involved in HUPO as the current HUPOST editor, on the Membership and Outreach Committee, and have presented and organized many sessions at past HUPO conferences. I am very active on social media, especially Twitter (go #TeamMassSpec!), and therefore I am also on the HUPO Social Media committee as well, where we are thinking of the best ways to promote our great organization. In 2020, I was honored with the HUPO Discovery in Proteomic Sciences award. I currently serve on the United States HUPO board of directors, and my goal over the next 3 years will be to engage US-HUPO to be more synergized with HUPO to advance both organization’s goals. I also hope to continue to support younger scientists by supporting new networking and mentoring opportunities, and helping to connect HUPO scientists to one another throughout the year (and not just at the HUPO Congress). At this point in my career, my primary objective is to make academia and our proteomics field more inclusive to everyone from different nationalities, cultures and backgrounds to diversify our amazing proteomics community. I have participated in many diversity committees in different scientific societies and organizations, and thus will make this my priority for my next term on the HUPO governing council.
Professor & Vice Chair, University of Nebraska Medical Center, USA
I would like to continue serving on the HUPO Council in order to directly support HUPO's efforts to study human development and disease through proteomic technologies. Throughout my career, I have had the opportunity to work at the interface of proteomics, regenerative medicine and developmental biology. Our laboratory develops and applies innovative technologies, bioinformatics tools, and methodologies to transform our understanding of cell surface proteins and glycans and answer outstanding questions in stem cell biology and cardiac pathology. Beyond our own research program, I am the Director of the CardiOmics Program at the University of Nebraska Medical Center where I am actively involved in engaging the biomedical community, promoting a broad range of molecular-level research, from biomarker discovery and validation to mechanistic studies, and providing educational opportunities regarding mass spectrometry analyses of biological molecules. The HUPO organization is well-positioned to enhance the continued expansion, standardization, and integration of proteomics into biomedical research. I would like to contribute to this goal, especially through participating in initiatives supporting standardizations in protein characterizations and phenotypic evaluation and the free and rapid exchange of data and analytical workflows. I am currently Co-Chair of the HUPO B/D HPP Cardiovascular Initiative and actively participate in the annual HUPO World Congresses. I am also on the Board of Directors for US HUPO.
Professor and Senior Scientist, University of Toronto and Princess Margaret Cancer Centre, Canada
I am trained as an analytical chemist and biochemist and I have been involved in proteomics research for over 20 years. My lab is located at the Princess Margaret Cancer Centre in Toronto and our group is primarily focused on clinical proteomics, biomarker discovery and cell surface target discovery. I have been on the Board of Directors of the Canadian National Proteomics Network since 2018 and have co-organized our annual meeting in 2017 in Toronto. I have leadership experience as chair of the Department of Medical Biophysics at the University of Toronto (2017-2023) one of Canada’s largest cancer biology and medical imaging graduate programs in North America. I am interested in contributing to HUPO to enhance biologically and clinically relevant applications of proteomics within the society.
Assistant Professor, Yale University School of Medicine, USA
Like everyone in HUPO, I have a keen interest in mass spectrometry and proteomics. I worked in shotgun and targeted MS such as S/MRM as a Ph.D. student. In 2011-2017, I completed a 6.5-year postdoctoral experience in Ruedi Aebersold lab at ETH Zurich, Switzerland, where I contributed to the development and application of a data-independent acquisition (DIA) method named SWATH-MS. In my current 5-year-old lab at Yale, our major scientific focuses are cancer aneuploidy and cellular signaling transduction. We also optimized, developed, and applied the pulse SILAC-DIA (pSILAC-DIA) technique to study the protein turnover for systems biological investigations.
My Ph.D. training took place in China, postdoctoral research in Europe, and independent scientific career in the USA. This fortunate experience gives me great opportunities to interact or collaborate with many proteomics scientists from many different regions and to appreciate their scientific work and intelligence deeply. I have always been a fan of HUPO. I served on the HUPO Award Committee for four years and the new HUPO Education and Training Committee since 2022. I received the 2021 ASMS Research Award and have served on the editorial board of Proteomics for five years. So far, I have co-authored 60 papers with total citations above 5700 times. I also participated a few times as a lecturer in the Targeted Proteomics Course. Additionally, I have reviewed >50 papers for Proteomics, JPR, JP, and MCP. As a maturing, early-to-mid career scientist of proteomics, I sincerely hope to contribute more and serve more to our community. I believe HUPO should engage more of the next generation of scientists, and I am eager to organize events in which young scientists, such as first-authors in manuscripts, can present and learn from each other.
Associate Professor, University of Sao Paulo, Brazil
I am Associate Professor at the Department of Parasitology, Institute of Biomedical Sciences, University of Sao Paulo, Brazil focusing on studying the host-pathogen interaction for neglected tropical diseases. My aim is to use mass spectrometry to elucidate the cellular and metabolic processes during host cell infection with parasites and identify potential diagnostic and therapeutic targets. I obtained my Ph.D. at the University of Bari (Italy) under the supervision of Prof. Sergio Papa and a postdoc at the University of Southern Denmark, under the supervision of Prof. Martin R. Larsen.
I will put all efforts and bring my national and international experience (Italy, Denmark and Brazil) to promote HUPO Mission and Goals. My preferred one is to disclose proteomics around the world and encourage young and recent docs and post-docs to work in the field as well as to associate them to HUPO. To further research on human diseases and on the Human Proteome Project is another strong believe that I´ll pursue. I have been member of the council of the Brazilian Mass Spectrometry (BRMASS) and Brazilian Proteomics societies (BRPROT). Based on this background, I aim at strengthen the interaction with proteomics societies in South America especially in Brazil with my election in the HUPO council. Moreover, I will continue the activities within HUPO as member of the Early Career Researcher (ECR) and Education and Training Committee (ETC) and promote them within the proteomics community.
Member (Full Professor), St. Jude Children's Research Hospital, USA
Dr. Junmin Peng is a Member (Professor) and the Director of Center for Proteomics and Metabolomics at St. Jude Children's Research Hospital in Memphis, Tennessee, USA. He is also an adjunct professor at the University of Tennessee Health Science Center in Memphis. In 1991, he obtained a B.S. degree in biochemistry at Wuhan University, China, and then received about three years of graduate training in plant genetics at the same University. He then moved to USA in 1994 and obtained his Ph.D. in biochemistry at the University of Iowa, where he cloned the transcription elongation factor P-TEFb (CDK9/cyclin T) under the guidance of Dr. David Price. He conducted his postdoctoral training at Harvard Medical School as a Jane Coffin Childs Fellow, in neurobiology (mentored by Dr. Li-Huei Tsai) and mass spectrometry/proteomics (mentored by Dr. Steven Gygi). In 2002, he joined Emory University as a faculty member and moved to St. Jude in 2011. Dr. Peng has been strongly interested in developing high-throughput mass spectrometry-based proteomics, metabolomics and systems biology approaches, and applying these approaches to biomedical challenges (e.g., ubiquitin biology, Alzheimer's disease and cancer). Beyond big data analysis, his group also develops functional experiments to validate derived hypotheses in cellular and animal models. He contributes to the establishment of target-decoy strategies for protein and metabolite identification, the original profiling of ubiquitinated proteome and synaptic proteome, and the identification of complex ubiquitin code, and the discovery of RNA splicing dysfunction and other novel disease genes/proteins in Alzheimer's disease. Dr. Peng serves as an Editorial Board Member for Molecular and Cellular Proteomics, and Molecular Neurodegeneration. He has published 200+ peer-reviewed scientific papers (30,000+ citations in Google Scholar), and has trained 80+ graduate students, postdocs and staff scientists.
Professor, Univ. of Texas Health Science Center at San Antonio, USA
I have been actively engaged in biomedical mass spectrometry since the early 1970’s, analyzing “small” molecules until the late 1990’s when my efforts shifted to proteomics. During this period, I have frequently participated as chair for review of NIH national MS resources (proteomics and glycomics) and grant applications for major instrumentation funding. After serving on the Editorial Board of the Journal of Proteome Research starting in 2007, I was an Associate Editor for the journal from 2011 to 2021 with focus on informatics and MS technology. Previously, my scientific society activities were predominantly with the American Society for Mass Spectrometry (ASMS). I was elected to the Board of Directors as Secretary and then Member-at Large for Publications and subsequently served a six-year term as VP Programs, President and Past-President. Following that commitment, I have had the time to become involved in various aspects of HUPO, starting with activities associated with the HPP, as the chair of the MS Resource Pillar and as a member of the HPP Executive Committee. I have also had the honor of serving on the HUPO Council for the past six years and as HUPO Vice President from 2020 to 2021. I am submitting this nomination in the hopes of serving another three-year term on the Council. I value the opportunity to attend the annual Council meeting and provide input to HUPO officers about future initiatives. However, I would like to see Council members have more involvement in the society than just attending one meeting a year. In particular, I feel that the Council can be an extremely valuable resource for the strategic plan that is currently under development. In summary, I am interested in capitalizing on my many years of experience in education, publication and scientific society organization and management for the benefit of HUPO.
Associate Professor, University of Oklahoma, USA
Dr. Wu received her Ph.D. (2006) in Analytical Chemistry at the Washington State University with Professor James E. Bruce. After graduation, she conducted her postdoctoral research on top-down proteomics at the Pacific Northwest National Laboratory (PNNL) with Drs. Ljiljiana Paša-Tolić and Richard D. Smith (2006-2008). Later, she worked as a research scientist at Battelle Toxicology Northwest (2008-2010) and as a senior scientist at PNNL (2010-2014). Currently, she is an associate professor in the Department of Chemistry and Biochemistry at the University of Oklahoma. Her research focuses on developing and development and application of novel high-throughput quantitative top-down and functional proteomics techniques to address important clinical and biological questions. She was named a “2017 ASMS Emerging investigator” by JASMS and received the USHUPO “Robert J. Cotter New Investigator Award" in 2020.
Dr. Wu currently sits on the editorial board of the Journal of Mass Spectrometry (JMS) and serves on the ASMS Publications Committee (2020-2022). Additionally, she has been a member of HUPO council since 2020 and is currently the co-chair for HUPO Nominations and Elections Committee.